abstract |
The present invention relates to a process for preparing [R-(R*,R*)]-5-(3-chlorophenyl)-3-[2-(3,4-dimethoxyphenyl)-1-methyl-ethyl]-oxazolidin-2-one of Formula (1), characterized in that said process comprises the step of reacting (R)-3, 4-methoxy-amphetamine of Formula (3), with (R)-3-chloro-mandelic acid, of Formula (9): <IMAGE> +TR <IMAGE> |